ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere
Status:
Unknown status
Trial end date:
2005-12-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine if DN-101 plus Taxotere lowers PSA levels, delays
or limits disease progression and is safe with minimal side effects.